Biomarkers in Cardiovascular Diseases

• Author : Dimitris Tousoulis,Christodoulos Stefanadis
• Publisher : CRC Press
• Release : 29 July 2013

The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics:

• Author : Michael Lichtenauer
• Publisher : MDPI
• Release : 28 December 2020

Cardiac biomarkers such as troponins and natiuretic peptides have made a great impact on clinical decision making as well as improving our understanding of molecular mechanisms of different disease conditions. However, the biomarkers that are currently in use do not reflect all the multiple disease pathways that are involved in a broad spectrum of cardiac disease conditions ranging from acute coronary syndrome, to heart failure (and heart failure with preserved ejection fraction, HFpEF), to pulmonary hypertension or arrhythmias. In this

• Author : Vijay Nambi
• Publisher : Elsevier Health Sciences
• Release : 27 November 2018

Get a quick, expert overview of the ways in which biomarkers can be used to assess and guide the management of cardiovascular disease in the clinical setting. This concise, clinically-focused resource by Dr. Vijay Nambi consolidates today’s available information on this rapidly changing topic into one convenient resource, making it an ideal, easy-to-digest reference for cardiology practitioners, fellows, and residents. Covers lab standards and statistical interpretation of biomarkers with a clinical focus. Discusses relevant conditions such as hypertension and

• Author : James L. Januzzi
• Publisher : Jones & Bartlett Learning
• Release : 04 July 2022

Cardiac Biomarkers in Clinical Practice was just honored with 4 Stars from Doody's Book Review! Cardiac Biomarkers in Clinical Practice presents a case based approach to biomarkers in heart diseases including heart failure, ischemic heart disease, and outpatient. Divided into six sections, this book provides physicians and other health care providers with a clear understanding of the role of biomarkers in clinical cardiovascular medicine.

• Author : Victor R. Preedy,Vinood B. Patel
• Publisher : Springer
• Release : 11 March 2016

In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of

• Author : David A. Morrow
• Publisher : Springer Science & Business Media
• Release : 28 April 2010

In the four pages committed to a discussion of myocardial infarction in the first edition of Harrison’s Principles of Internal Medicine, published in 1950, there was no mention of use of the laboratory for management of patients. Thirty years later, when the first edition of Braunwald’s Heart Disease, A Textbook of Cardiovascular Medicine was published, 2 out of the 1943 pages in the text contained a discussion of the laboratory examinations in acute myocardial infarction. Our knowledge base of the multitude

• Author : Alan S. Maisel,Allan S. Jaffe
• Publisher : Springer
• Release : 24 October 2016

This book covers ACS and Heart Failure, the chapters represent the most current, up to date and knowledgeable content on the topic available. It is written by the worlds most respected leaders in biomarkers, with a majority emphasis on what clinicians need to know. The Editors and their contributors have provided algorithms, annotated case discussions and caveats. They cover biomarkers to predict risk of heart disease, biomarkers of cardiorenal disease , and conclude with a section on new and emerging biomarkers.

• Author : Alan S Maisel
• Publisher : JAYPEE BROTHERS PUBLISHERS
• Release : 13 March 2012

The purpose of the book is nicely worded in the introduction: 'make good doctors better'. Motivate the clinicians to use biomarkers to obtain up-to-date background knowledge regarding tools they use every day clinically, such as cardiac troponin and natriuretic peptides. Biomarkers have become essential clinical tools in the early diagnosis of acute myocardial infarction and the early diagnosis of heart failure, as well as potentially helpful tools in many other indications. Beyond doubt, Cardiac Biomarkers-Expert Advice for Clinicians will achieve

• Author : James de Lemos
• Publisher : John Wiley & Sons
• Release : 26 January 2009

Biomarkers in Heart Disease is the first title in the AHAClinical Series and is aimed at meeting the needs of clinicians,providing cardiologists, internists, emergency physicians,laboratorians, and other healthcare providers with a clearunderstanding of the role of biomarkers in contemporarycardiovascular medicine. The book covers both the strengths and pitfalls of currentlyavailable markers, and provides information on the most promisingbiomarkers that are likely to impact practice in the next fewyears. It is divided into four parts, organized around clinicalscenarios rather

• Author : Michael Lichtenauer
• Publisher : Unknown
• Release : 04 July 2022

Cardiac biomarkers such as troponins and natiuretic peptides have made a great impact on clinical decision making as well as improving our understanding of molecular mechanisms of different disease conditions. However, the biomarkers that are currently in use do not reflect all the multiple disease pathways that are involved in a broad spectrum of cardiac disease conditions ranging from acute coronary syndrome, to heart failure (and heart failure with preserved ejection fraction, HFpEF), to pulmonary hypertension or arrhythmias. In this

• Author : Haley Jean McClory
• Publisher : Unknown
• Release : 04 July 2022

• Author : Thijs Jan Zweers
• Publisher : Unknown
• Release : 04 July 2022

• Author : Michael Largen
• Publisher : Unknown
• Release : 04 July 2022

• Author : Juan Antonio Vílchez,María Dolores Albaladejo-Otón
• Publisher : Bentham Science Publishers
• Release : 29 September 2017

Biomarkers are any measurable biochemical characteristics of an organism that reflect a particular physiological state. Biomarkers can take many different forms including particular proteins or peptides, antibodies, cell types, metabolites, hormones, enzyme levels, compounds related to genomics, etc. A biomarker can also be a substance introduced into a patient to assess the internal organ systems role. In medicine, biomarkers considered as compounds isolated from serum, urine, or other fluids, can be used as an indicator of the presence or severity

• Author : Kent Balanis Lewandrowski
• Publisher : Elsevier Health Sciences
• Release : 15 February 2014

Topics in this clinically focused publication devoted to Cardiac Markers include: Overview of cardiac markers in heart disease; Methodologies for measurement of cardiac markers; Natriuretic peptides in HF and ACS; Tropoinins and high sensitivity troponins; Point-of-care testing for cardiac markers; ST-2 and galectin 3 in patients with heart failure; Cardiac markers following heart surgery and percutaneous coronary intervention; Cholesterol, lipoproteins, high sensitivity CRP and other risk factors for atherosclerosis; Myocarditis and cardiac transplant and rejection; New molecular genetic tests in the